← Back to headlines
Pfizer Secures China Nod for Obesity Drug as Generics Loom
Pfizer has received approval in China for its obesity drug, positioning itself in the market as generic alternatives are anticipated.
6 Mar, 06:35 — 6 Mar, 06:35
Sources
Showing 1 of 1 sources
